Funded Project Details - FY2021
|Title:|| CSP 553 - Adjuvant Therapy For High Risk Prostate Carcinoma: Docetazel & High Dose Calcitriol (DECAL)|
Daniel W. Lin
|| June 2005 -
|FY 2021 Funding Amount:
|Total Award Amount
See Cooperative Studies Program (CSP) for details on active studies, approved studies, studies in planning, centers, etc.
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.